| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048392 Plant extract mixtures and their uses |
| 03/01/2007 | US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | CA2622904A1 Self-assembling nanoparticles for the treatment of vascular diseases |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2620026A1 Method for production of single- and multi-layer microcapsules |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757686A1 Cell death inducer |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1757610A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757599A1 Indole derivatives having piperidine rings |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757297A1 Composition for inhibiting the onset of arteriosclerosis and inhibition method |
| 02/28/2007 | EP1757296A1 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 02/28/2007 | EP1757291A2 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-YL)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1756143A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 02/28/2007 | EP1755614A1 Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1458703B1 Isochroman compounds for treatment of cns disorders |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1429807B1 Combination of a nsaid and a pde-4 inhibitor |
| 02/28/2007 | EP1418912B1 Isoxazolopyridinones |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1381397B1 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 02/28/2007 | EP1379505B1 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1337258A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1239776B1 Surgical needle with weeping tip |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1150695B1 Herbal supplement for increased muscle strength and endurance for athletes |
| 02/28/2007 | EP1085811B1 Broad specificity dna damage endonuclease |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP1033979B9 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921883A Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 02/28/2007 | CN1921876A Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug |
| 02/28/2007 | CN1921875A Beverage and medicine having bamboo extractive as main component |
| 02/28/2007 | CN1921869A Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same |
| 02/28/2007 | CN1921859A Indole derivatives for the treatment of bone diseases |
| 02/28/2007 | CN1921846A Combinatorial therapy with an acetylcholinesterase inhibitor and (3AR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919847A Novel hydrochloride compound and use thereof |
| 02/28/2007 | CN1919299A Medicine for toxin removing, clots absorbing and body strengthening |
| 02/28/2007 | CN1919269A Umbilicus applying medicine for treating night sweat due to weak body physique and its preparing process |
| 02/28/2007 | CN1919258A Application of schisandra chinensis in the preparation of medicine for preventing and reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919204A Method for enhancing nutrient absorption with astragalosides |
| 02/28/2007 | CN1919203A Method for enhancing nutrient absorption with astragalosides |
| 02/28/2007 | CN1919193A Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919183A Pilocarpine nitrate dispersible tablet and preparation method thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 02/28/2007 | CN1301981C Medicinal composition containing 1,3-thiazine derivative |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301972C Piperidine compounds as muscarinic antagonists |
| 02/28/2007 | CN1301970C 2,4-substituted indoles and their use as 5-HT6 modulators |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301742C Chinese medical preparation for preventing and curing blaze of shrimps corpus hemorrhagicum, gill rot and pond syndrome |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183375 Invention relates to peptide sequence which inhibits cleavage of calcineurin subunit A by calpain; cell death suppressant targeting the mechanism of the long term activation of calcineurin but not the calcineurin activation through the transient increase of the intracellular concentration of calcium |
| 02/27/2007 | US7183322 Remedy for hypertension |